Author: Musafia Boaz Senderowitz Hanoch
Publisher: Informa Healthcare
ISSN: 1746-0441
Source: Expert Opinion on Drug Discovery, Vol.5, Iss.10, 2010-10, pp. : 943-959
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Ligand-Based Drug Design of Novel MARK-3 Inhibitors in Cancer
Current Bioactive Compounds, Vol. 10, Iss. 2, 2014-07 ,pp. :